Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis

被引:139
|
作者
Selman, M
Lin, HM
Montaño, M
Jenkins, AL
Estrada, A
Lin, ZW
Wang, GR
DiAngelo, SL
Guo, XX
Umstead, TM
Lang, CM
Pardo, A
Phelps, DS
Floros, J [1 ]
机构
[1] Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA
[2] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico
[3] Penn State Univ, Dept Hlth Evaluat Sci, Coll Med, Hershey, PA 17033 USA
[4] Penn State Univ, Dept Pediat, Coll Med, Hershey, PA 17033 USA
[5] Penn State Univ, Dept Comparat Med, Coll Med, Hershey, PA 17033 USA
[6] Penn State Univ, Dept Obstet & Gynecol, Coll Med, Hershey, PA 17033 USA
[7] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico
关键词
D O I
10.1007/s00439-003-1015-4
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Derangement in pulmonary surfactant or its components and alveolar collapse are common findings in idiopathic pulmonary fibrosis (IPF). Surfactant proteins play important roles in innate host defense and normal function of the lung. We examined associations between IPF and genetic polymorphic variants of surfactant proteins, SP-A1, SP-A2, SP-B, SP-C, and SP-D. One SP-A1 (6A(4)) allele and single nucleotide polymorphisms (SNPs) that characterize the 6A(4) allele, and one SP-B (B1580_C) were found with higher frequency (Pless than or equal to0.01) in nonsmoker and smoker IPF (n=84) subgroups, respectively, compared with healthy controls (n=194). To explore whether a tryptophan (present in 6A(4)) or an arginine (present in other SP-A1 alleles and in all SP-A2 alleles) at amino acid 219 alters protein behavior, two truncated proteins that varied only at amino acid 219 were oxidized by exposure to ozone. Differences in the absorption spectra (310-350 nm) between the two truncated recombinant SP-A proteins were observed both before and after protein oxidation, suggesting allele-specific aggregation differences attributable to amino acid 219. The SP-B SNP B1580_C (odds ratio:7.63; confidence interval:1.64-35.4; Pless than or equal to0.01), to be a risk factor for IPF smokers, has also been shown to be a risk factor for other pulmonary diseases. The SP-C and SP-D SNPs and SP-B-linked microsatellite markers studied did not associate with IPF. These findings indicate that surfactant protein variants may serve as markers to identify subgroups of patients at risk, and we speculate that these contribute to IPF pathogenesis.
引用
收藏
页码:542 / 550
页数:9
相关论文
共 50 条
  • [21] Serum Surfactant Protein-A Is a Strong Predictor of Early Mortality in Idiopathic Pulmonary Fibrosis
    Kinder, Brent W.
    Brown, Kevin K.
    McCormack, Francis X.
    Ix, Joachim H.
    Kervitsky, Alma
    Schwarz, Marvin I.
    King, Talmadge E., Jr.
    CHEST, 2009, 135 (06) : 1557 - 1563
  • [22] Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis
    Ikeda, Kimiyuki
    Shiratori, Masanori
    Yokoo, Keiki
    Ohtsuka, Mitsuo
    Chiba, Hirofumi
    Takahashi, Hiroki
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [23] Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis
    Phelps, DS
    Umstead, TM
    Mejia, M
    Carrillo, G
    Pardo, A
    Selman, M
    CHEST, 2004, 125 (02) : 617 - 625
  • [24] ELEVATED LEVELS OF PULMONARY SURFACTANT PROTEIN-A (SP-A) IN SERA OF IDIOPATHIC PULMONARY FIBROSIS AND PULMONARY ALVEOLAR PROTEINOSIS
    HONDA, Y
    KUROKI, Y
    SHIJUBO, N
    TSUTAHARA, S
    TAKAHASHI, H
    ABE, S
    AKINO, T
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A986 - A986
  • [25] Rare and Common Variants in KIF15 Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis
    Zhang, David
    Povysil, Gundula
    Kobeissy, Philippe H.
    Li, Qi
    Wang, Binhan
    Amelotte, Mason
    Jaouadi, Hager
    Newton, Chad A.
    Maher, Toby M.
    Molyneaux, Philip L.
    Noth, Imre
    Martinez, Fernando J.
    Raghu, Ganesh
    Todd, Jamie L.
    Palmer, Scott M.
    Haefliger, Carolina
    Platt, Adam
    Petrovski, Slave
    Garcia, Joseph A.
    Goldstein, David B.
    Garcia, Christine Kim
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (01) : 56 - 69
  • [26] Common Idiopathic Pulmonary Fibrosis (IPF) Genetic Variants Are Associated with Chronic Hypersensitivity Pneumonitis (CHP)
    Furusawa, H.
    Cardwell, J. H.
    Peljto, A. L.
    Walts, A. D.
    Bang, T. J.
    Cool, C. D.
    Lee, J. S.
    Wolters, P. J.
    Yang, I. V.
    Schwartz, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [27] Towards genetic reclassification of idiopathic pulmonary fibrosis
    Wain, Louise
    LANCET RESPIRATORY MEDICINE, 2018, 6 (08): : 569 - 570
  • [28] Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone
    Weng, Jie
    Tu, Mengyun
    Yang, Bo
    Wang, Zhiyi
    RESPIRATORY MEDICINE, 2018, 145 : 228 - 228
  • [29] Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone
    Ikeda, Kimiyuki
    Shiratori, Masanori
    Chiba, Hirofumi
    Nishikiori, Hirotaka
    Yokoo, Keiki
    Saito, Atsushi
    Hasegawa, Yoshihiro
    Kuronuma, Koji
    Otsuka, Mitsuo
    Yamada, Gen
    Takahashi, Hiroki
    RESPIRATORY MEDICINE, 2017, 131 : 184 - 191
  • [30] The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D
    Takuya Samukawa
    Tsutomu Hamada
    Hirofumi Uto
    Masakazu Yanagi
    Go Tsukuya
    Tsuyoshi Nosaki
    Masahiro Maeda
    Takashi Hirano
    Hirohito Tsubouchi
    Hiromasa Inoue
    BMC Pulmonary Medicine, 12